Dr. Reddy's Laboratories informs about press release

17 Oct 2020 Evaluate
Dr. Reddy's Laboratories has informed that it has enclosed press release titled ‘Dr. Reddy's and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

6263.70 46.55 (0.75%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.